Literature DB >> 18039179

A role for PFK-2/FBPase-2, as distinct from fructose 2,6-bisphosphate, in regulation of insulin secretion in pancreatic beta-cells.

Catherine Arden1, Laura J Hampson, Guo C Huang, James A M Shaw, Ali Aldibbiat, Graham Holliman, Derek Manas, Salmaan Khan, Alex J Lange, Loranne Agius.   

Abstract

PFK-2/FBPase-2 (6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase) catalyses the formation and degradation of fructose 2,6-P(2) (fructose 2,6-bisphosphate) and is also a glucokinase-binding protein. The role of fructose 2,6-P(2) in regulating glucose metabolism and insulin secretion in pancreatic beta-cells is unresolved. We down-regulated the endogenous isoforms of PFK-2/FBPase-2 with siRNA (small interfering RNA) and expressed KA (kinase active) and KD (kinase deficient) variants to distinguish between the role of PFK-2/FBPase-2 protein and the role of its product, fructose 2,6-P(2), in regulating beta-cell function. Human islets expressed the PFKFB2 (the gene encoding isoform 2 of the PFK2/FBPase2 protein) and PFKFB3 (the gene encoding isoform 3 of the PFK2/FBPase2 protein) isoforms and mouse islets expressed PFKFB2 at the mRNA level [RT-PCR (reverse transcription-PCR)]. Rat islets expressed PFKFB2 lacking the C-terminal phosphorylation sites. The glucose-responsive MIN6 and INS1E cell lines expressed PFKFB2 and PFKFB3. PFK-2 activity and the cell content of fructose 2,6-P(2) were increased by elevated glucose concentration and during pharmacological activation of AMPK (AMP-activated protein kinase), which also increased insulin secretion. Partial down-regulation of endogenous PFKFB2 and PFKFB3 in INS1E by siRNA decreased PFK-2/FBPase-2 protein, fructose 2,6-P(2) content, glucokinase activity and glucoseinduced insulin secretion. Selective down-regulation of glucose-induced fructose 2,6-P(2) in the absence of down-regulation of PFK-2/FBPase-2 protein, using a KD PFK-2/FBPase-2 variant, resulted in sustained glycolysis and elevated glucose-induced insulin secretion, indicating an over-riding role of PFK-2/FBPase-2 protein, as distinct from its product fructose 2,6-P(2), in potentiating glucose-induced insulin secretion. Whereas down-regulation of PFK-2/FBPase-2 decreased glucokinase activity, overexpression of PFK-2/FBPase-2 only affected glucokinase distribution. It is concluded that PFK-2/FBPase-2 protein rather than its product fructose 2,6-P(2) is the over-riding determinant of glucose-induced insulin secretion through regulation of glucokinase activity or subcellular targeting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18039179     DOI: 10.1042/BJ20070962

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  A cis-eQTL in PFKFB2 is associated with diabetic nephropathy, adiposity and insulin secretion in American Indians.

Authors:  Yunhua L Muller; Paolo Piaggi; Robert L Hanson; Sayuko Kobes; Shujera Bhutta; Maryam Abdussamad; Tennille Leak-Johnson; Matthias Kretzler; Ke Huang; E Jennifer Weil; Robert G Nelson; William C Knowler; Clifton Bogardus; Leslie J Baier
Journal:  Hum Mol Genet       Date:  2015-02-06       Impact factor: 6.150

Review 2.  A fresh view of glycolysis and glucokinase regulation: history and current status.

Authors:  Sigurd Lenzen
Journal:  J Biol Chem       Date:  2014-03-17       Impact factor: 5.157

3.  Androgen receptor-deficient islet β-cells exhibit alteration in genetic markers of insulin secretion and inflammation. A transcriptome analysis in the male mouse.

Authors:  Weiwei Xu; Tianhua Niu; Beibei Xu; Guadalupe Navarro; Matthew J Schipma; Franck Mauvais-Jarvis
Journal:  J Diabetes Complications       Date:  2017-03-09       Impact factor: 2.852

4.  Hypothalamic responses to fasting indicate metabolic reprogramming away from glycolysis toward lipid oxidation.

Authors:  Michal M Poplawski; Jason W Mastaitis; Xue-Jun Yang; Charles V Mobbs
Journal:  Endocrinology       Date:  2010-09-29       Impact factor: 4.736

5.  RNA Sequencing Exposes Adaptive and Immune Responses to Intrauterine Growth Restriction in Fetal Sheep Islets.

Authors:  Amy C Kelly; Christopher A Bidwell; Fiona M McCarthy; David J Taska; Miranda J Anderson; Leticia E Camacho; Sean W Limesand
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

Review 6.  Emerging role of testosterone in pancreatic β-cell function and insulin secretion.

Authors:  Weiwei Xu; Jamie Morford; Franck Mauvais-Jarvis
Journal:  J Endocrinol       Date:  2019-01-01       Impact factor: 4.286

Review 7.  Molecular and cellular regulation of human glucokinase.

Authors:  Shawn M Sternisha; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2019-01-11       Impact factor: 4.013

8.  Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter.

Authors:  John L Petrie; Ziad H Al-Oanzi; Catherine Arden; Susan J Tudhope; Jelena Mann; Julius Kieswich; Muhammad M Yaqoob; Howard C Towle; Loranne Agius
Journal:  Mol Cell Biol       Date:  2012-12-03       Impact factor: 4.272

9.  Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis.

Authors:  Catherine Arden; John L Petrie; Susan J Tudhope; Ziad Al-Oanzi; Amy J Claydon; Robert J Beynon; Howard C Towle; Loranne Agius
Journal:  Diabetes       Date:  2011-10-19       Impact factor: 9.461

10.  Transcriptional adaptations following exercise in thoroughbred horse skeletal muscle highlights molecular mechanisms that lead to muscle hypertrophy.

Authors:  Beatrice A McGivney; Suzanne S Eivers; David E MacHugh; James N MacLeod; Grace M O'Gorman; Stephen D E Park; Lisa M Katz; Emmeline W Hill
Journal:  BMC Genomics       Date:  2009-12-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.